BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260302
DTEND;VALUE=DATE:20260304
DTSTAMP:20260418T065112
CREATED:20251121T115047Z
LAST-MODIFIED:20251121T160045Z
UID:9559-1772409600-1772582399@thebiocalendar.com
SUMMARY:BIO Investment and Growth Summit
DESCRIPTION:This premier conference brings together newly public and select private biotech companies with the investment banking community for two days of business and regulatory sessions\, Company Presentations\, BIO Partnering™\, and networking. \nJoin us in Miami Beach for two impactful days as we address the most pressing issues facing our industry\, from navigating the financial landscape for life sciences to tackling the ever-changing regulatory and policy challenges that affect biotech companies of all sizes. You’ll also have the opportunity to build relationships with strategic partners for investment and receive guidance on capital formation\, commercialization\, reimbursement\, and growth.
URL:https://thebiocalendar.com/event/bio-investment-and-growth-summit/
LOCATION:Miami Beach\, Miami Beach\, FL\, 33139\, United States
CATEGORIES:Investor,Networking
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260303T110000
DTEND;TZID=America/Los_Angeles:20260303T120000
DTSTAMP:20260418T065112
CREATED:20260129T145423Z
LAST-MODIFIED:20260205T132200Z
UID:9834-1772535600-1772539200@thebiocalendar.com
SUMMARY:The Future of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness
DESCRIPTION:Transform your CGT manufacturing from a regulatory bottleneck into a competitive powerhouse. Learn how digital integration slashes release times and harmonizes FDA/EMA compliance. You’ll walk away with a clear roadmap for scaling “batch-of-one” production using real-time analytics\, ensuring your operations are both future-proof and ready for global commercialization.
URL:https://thebiocalendar.com/event/the-future-of-cgt-manufacturing-panel-discussion-integrating-digital-solutions-with-regulatory-readiness/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/03-03-26-MasterControl-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260303T110000
DTEND;TZID=America/Los_Angeles:20260303T120000
DTSTAMP:20260418T065112
CREATED:20260205T142903Z
LAST-MODIFIED:20260205T142903Z
UID:9851-1772535600-1772539200@thebiocalendar.com
SUMMARY:Where Biologic Stability Programs Fail—and How ICH Q1 Can Help You Get It Right (Free Webinar)
DESCRIPTION:The draft ICH Q1 guidance marks a major shift in biologics stability\, turning it from a back-end regulatory task into a front-line\, risk-based development discipline. This session explores why traditional approaches fall short\, where hidden risks emerge late\, and how ICH Q1 can be applied to strengthen programs across the product lifecycle. \nYou’ll learn how to:\n– Identify common stability program failures that surface during INDs\, comparability\, and scale-up\n– Apply ICH Q1 principles to real-world storage\, excursion studies\, and forced degradation\n– Reduce late-stage regulatory\, analytical\, and supply-chain risk\n– Build stability strategies that support confident IND\, BLA\, and commercial execution
URL:https://thebiocalendar.com/event/where-biologic-stability-programs-fail-and-how-ich-q1-can-help-you-get-it-right-free-webinar/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-03-26-Catalent-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260303T110000
DTEND;TZID=America/Los_Angeles:20260303T120000
DTSTAMP:20260418T065112
CREATED:20260205T185723Z
LAST-MODIFIED:20260205T185723Z
UID:9855-1772535600-1772539200@thebiocalendar.com
SUMMARY:The Future of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness
DESCRIPTION:Cell and gene therapy manufacturing is evolving fast—and scaling successfully now requires more than just meeting regulatory expectations. It requires turning them into an advantage. \nOur Panel will explore how leading CGT manufacturers are navigating cGMP complexity\, harmonizing FDA and EMA requirements\, and using digital tools to embed quality at the source—while scaling from batch-of-one to commercial production. The panel will also share practical guidance on building a paperless foundation\, accelerating release times\, and preparing for what digitally mature CGT operations will look like over the next five years. \nIf you’re involved in CGT manufacturing\, quality\, regulatory\, or digital transformation\, this is the event for you.
URL:https://thebiocalendar.com/event/the-future-of-cgt-manufacturing-panel-discussion-integrating-digital-solutions-with-regulatory-readiness-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-03-26-MasterControl-LinkedIn-1280x720-OD.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260307
DTSTAMP:20260418T065112
CREATED:20251206T095552Z
LAST-MODIFIED:20251206T095552Z
UID:9621-1772582400-1772841599@thebiocalendar.com
SUMMARY:PMWC
DESCRIPTION:PMWC\, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders\, top global researchers and medical professionals\, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors\, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine. \nSince 2009\, recognized as a vital cornerstone for all constituents of the health care and biotechnology community\, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology)\, in clinical implementation (e.g. cancer and beyond)\, research\, and in all aspects related to the regulatory and reimbursement sectors.
URL:https://thebiocalendar.com/event/pmwc/
LOCATION:Santa Clara\, Santa Clara\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260304T100000
DTEND;TZID=America/Los_Angeles:20260304T120000
DTSTAMP:20260418T065112
CREATED:20260121T131008Z
LAST-MODIFIED:20260121T131008Z
UID:9796-1772618400-1772625600@thebiocalendar.com
SUMMARY:Smart Sourcing: EDC\, eCOA\, & Data Management Showcase - Accelerate Your Trial Technology Decision
DESCRIPTION:Join us for a 2-hour virtual expo designed to help clinical trial professionals discover and compare the best Electronic Data Capture (EDC)\, electronic Clinical Outcome Assessment (eCOA)\, & Data Management technologies on the market\, without the time\, cost\, or travel of traditional conferences. \nWhether you are mid-trial or preparing for your next protocol\, this showcase gives you direct access to leading vendors\, each presenting their solution in a concise\, 15-minute demo format. \n✔ See real-world capabilities\n✔ Compare multiple providers side by side\n✔ Ask questions and get answers in real time\n✔ Get the insights that matter to your trial \nThis event is ideal for clinical operations\, data management\, and procurement teams at pharmaceutical and biotech companies. \nYou’ll leave with a clearer picture of your options and the confidence to move faster in selecting the right partners for your study.
URL:https://thebiocalendar.com/event/smart-sourcing-edc-ecoa-data-management-showcase-accelerate-your-trial-technology-decision/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/03-2026-CLSE-230x90-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260304T110000
DTEND;TZID=America/Los_Angeles:20260304T120000
DTSTAMP:20260418T065112
CREATED:20260205T132031Z
LAST-MODIFIED:20260205T132304Z
UID:9847-1772622000-1772625600@thebiocalendar.com
SUMMARY:Translating Stem Cell Programs to GMP: A Collaborative Approach to Overcoming Manufacturing Complexity
DESCRIPTION:Stem cells are a powerful frontier in cell and gene therapy\, offering pluripotency\, self-renewal\, and the ability to produce engineered\, standardized therapeutic cell populations. iPSC platforms reduce donor variability and support scalable\, consistent manufacturing for regenerative medicine\, gene correction\, and next-generation cell therapies. However\, stem cell products are inherently process-defined: cell identity\, function\, potency\, and safety are tightly linked to differentiation workflows\, handling conditions\, and manufacturing control. Even small process changes can significantly impact outcomes\, increasing complexity as programs move toward GMP. \nIn this webinar\, Meytal Haviv\, a Process Development Scientist at Landmark Bio\, will walk through common challenges teams encounter when advancing stem cell programs toward GMP\, including RUO-to-GMP process redesign\, operator-dependent variability risk\, scaling limitations\, raw material constraints\, and analytical alignment with regulatory expectations. Drawing on real-world development experience\, the discussion will focus on program design considerations and execution frameworks for process control\, cross-functional coordination\, tech transfer\, and early GMP planning that influence reproducibility and risk as iPSC and stem cell programs move from development to clinic. \nKey Learning Objectives:\n    Understand the unique process and scale challenges in stem cell manufacturing\n    Identify strategies to reduce variability and risk\, improving GMP readiness\n    Collaborative approaches to translating stem cell processes from PD to GMP efficiently and successfully
URL:https://thebiocalendar.com/event/translating-stem-cell-programs-to-gmp-a-collaborative-approach-to-overcoming-manufacturing-complexity/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/030426_landmark_bio_reg_1920x250_01.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260310
DTEND;VALUE=DATE:20260312
DTSTAMP:20260418T065112
CREATED:20251121T114921Z
LAST-MODIFIED:20251121T114921Z
UID:9557-1773100800-1773273599@thebiocalendar.com
SUMMARY:Investival Showcase USA
DESCRIPTION:Connecting life science & healthcare executives with capital & partners\nRevolutionizing Healthcare: Where Visionary Life-Science Innovators Secure Game-Changing Capital and Partnerships \nJoin us in Miami on March 10-11\, 2026\, for Investival Showcase USA\, North America’s premier biotech\, medtech\, and digital health networking event. \nThis cutting-edge platform connects innovators with investors and partners through exclusive 1:1 sessions. Building on a decade of European success\, we’re bringing this dynamic format stateside. Whether you’re a start-up or seasoned investor\, don’t miss this opportunity to shape the future of healthcare innovation in vibrant Miami.
URL:https://thebiocalendar.com/event/investival-showcase-usa/
LOCATION:Miami Beach\, Miami Beach\, FL\, 33139\, United States
CATEGORIES:Investor,Networking
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260310T110000
DTEND;TZID=America/Los_Angeles:20260310T120000
DTSTAMP:20260418T065112
CREATED:20260211T174323Z
LAST-MODIFIED:20260211T174323Z
UID:9863-1773140400-1773144000@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Large Molecule (Free Virtual Event)
DESCRIPTION:Watch leading CDMOs showcase their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your large molecule development and manufacturing needs. \nExplore the biopharmaceutical landscape\, including:\n– Cell line development\, fermentation\, and advanced purification\n– Process optimization and scale-up to meet production demands efficiently\n– Rigorous quality control practices that support the development of novel biologic therapies \nWhat to expect:\n– Short digital presentations providing an inside look at supplier capabilities\n– Live Q&A to ask questions and assess whether each CDMO meets your needs\n– Convenient access from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners aligned with their outsourcing requirements.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-large-molecule-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260310T130000
DTEND;TZID=America/Los_Angeles:20260310T140000
DTSTAMP:20260418T065112
CREATED:20260211T174848Z
LAST-MODIFIED:20260211T174848Z
UID:9867-1773147600-1773151200@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Fill/Finish (Free Virtual Event)
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify options for your fill/finish development and manufacturing needs. \nExplore the critical final steps of pharmaceutical manufacturing\, including:\n– Sterile filling and lyophilization (freeze drying)\n– Advanced packaging technologies\n– Quality control and regulatory compliance to ensure safe\, effective biopharmaceutical delivery \nWhat to expect:\n– Short digital presentations with live interaction for an inside look at supplier capacity\n– Opportunity to ask questions and assess if each CDMO can meet your needs\n– All accessible from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking available capacity and CDMO partners who can meet those needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-fill-finish-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260311T110000
DTEND;TZID=America/Los_Angeles:20260311T120000
DTSTAMP:20260418T065112
CREATED:20260211T175326Z
LAST-MODIFIED:20260211T175326Z
UID:9871-1773226800-1773230400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Small Molecule Drug Substance (Free Virtual Event)
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your small molecule drug substance development and manufacturing needs. \nWhat to expect:\n– Short digital presentations providing an inside look at supplier capacity\n– Live Q&A to ask questions and assess whether each CDMO can meet your needs\n– Convenient access from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with capabilities that match their needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-small-molecule-drug-substance-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260311T140000
DTEND;TZID=America/Los_Angeles:20260311T150000
DTSTAMP:20260418T065112
CREATED:20260304T194414Z
LAST-MODIFIED:20260304T194414Z
UID:9991-1773237600-1773241200@thebiocalendar.com
SUMMARY:The Hidden Costs of In Vivo Research: Avoiding Budget Pitfalls to Maximize Study Success Date
DESCRIPTION:Moving into the in vivo stage of drug development means decision have greater impact and risk. Whether ensuring animal health and genetics or securing vivarium lab space\, the choices you make now can have a major impact on your timeline and budget. Yet\, many early-stage teams are unaware of the hidden costs that can derail progress and strain resources. \nJoin our webinar to uncover the hidden costs and discover practical strategies to avoid them. You’ll learn how to plan smarter\, align your resources with therapeutic goals\, and set your program up for success before your study begins. Whether you’re an academic researcher\, a biotech team leader\, or an early-stage drug developer\, this session is designed to help you make informed decisions that keep your research on track while saving time and money. \nYou’ll learn: \n\nHow to identify and avoid common budget pitfalls in the preclinical in vivo stage\nBest practices for selecting animal models that align with your therapeutic objectives\nWhy engaging model experts early and planning for animal health and genetics can prevent costly delays\nKey questions to ask during vendor evaluations to ensure operational support and facility readiness
URL:https://thebiocalendar.com/event/the-hidden-costs-of-in-vivo-research-avoiding-budget-pitfalls-to-maximize-study-success-date/
LOCATION:Online webinar\, United States
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260311T170000
DTEND;TZID=America/Los_Angeles:20260311T193000
DTSTAMP:20260418T065112
CREATED:20260214T143446Z
LAST-MODIFIED:20260214T143446Z
UID:9905-1773248400-1773257400@thebiocalendar.com
SUMMARY:LSPA Annual Dinner & Showcase
DESCRIPTION:March 11\, 2026\nPhiladelphia Museum of Art\n5:00pm – 7:30pm\n\n\n\n\n\n\n\n\nThe premier social event for the Life Sciences Industry\nEach year\, Life Sciences PA hosts a celebration to honor the innovation and commitment our members have made to the life sciences industry. Join us at the Philadelphia Museum of Art to celebrate the award honorees and leaders of the past who have helped shape Pennsylvania’s life sciences industry at the Annual Dinner & Showcase. 
URL:https://thebiocalendar.com/event/lspa-annual-dinner-showcase/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260312T130000
DTEND;TZID=America/Los_Angeles:20260312T140000
DTSTAMP:20260418T065112
CREATED:20260211T180412Z
LAST-MODIFIED:20260211T180412Z
UID:9883-1773320400-1773324000@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Analytical Services (Free Virtual Event)
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your analytical services needs. \nTopics include:\n– Advanced assay development and method validation\n– Analytical platforms for large molecules\, biomarkers\, and emerging therapeutic modalities\n– Solutions tailored to the unique challenges of modern therapeutics \nWhat to expect:\n– Short digital presentations providing an inside look at supplier capacity\n– Live Q&A to ask questions and evaluate whether each CDMO can meet your needs\n– Convenient access from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with capabilities that fit their needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-analytical-services-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T000000
DTEND;TZID=America/Los_Angeles:20260319T235959
DTSTAMP:20260418T065112
CREATED:20251107T152844Z
LAST-MODIFIED:20251107T152844Z
UID:9472-1773705600-1773964799@thebiocalendar.com
SUMMARY:Rare Disease Summit
DESCRIPTION:The Rare Disease Summit\, March 17-19\, 2026 in Philadelphia\, PA\, unites stakeholders to accelerate therapeutic innovation for areas of unmet medical need. Gain actionable insights on launch planning\, market access\, reimbursement strategies and strategic partnerships to optimize rare disease commercialization and elevate patient impact. Learn more at www.informaconnect.com/rare. Save 10% with code 26B4B10.*
URL:https://thebiocalendar.com/event/rare-disease-summit-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/RareDisease_EmailHeaders20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260317T080000
DTEND;TZID=America/New_York:20260319T170000
DTSTAMP:20260418T065112
CREATED:20251107T153148Z
LAST-MODIFIED:20251107T153148Z
UID:9476-1773734400-1773939600@thebiocalendar.com
SUMMARY:PAP – Patient Assistance & Access Programs
DESCRIPTION:Stakeholders unite at the ultimate forum – PAP – Patient Assistance & Access Programs convenes influential stakeholders and top leaders from across the assistance\, access and affordability arena to talk strategies for program optimization and provide crucial updates on evolving health policy and shifting market dynamics to transform patient outcomes\, maximize medication access and prioritize the patient experience. Prepare for crucial discussions to maximize patient access and robust networking opportunities to expand your network and establish powerful partnerships.
URL:https://thebiocalendar.com/event/pap-patient-assistance-access-programs-3/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/PAP26_600x200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T080000
DTEND;TZID=America/Los_Angeles:20260319T170000
DTSTAMP:20260418T065112
CREATED:20251107T153243Z
LAST-MODIFIED:20251107T153243Z
UID:9480-1773734400-1773939600@thebiocalendar.com
SUMMARY:Hub and Specialty Pharmacy Models East
DESCRIPTION:Unlock your hub’s fullest potential at Hub and Specialty Pharmacy Models East. Key stakeholders unite to collaborate and discuss evolving regulations\, shifting market dynamics and innovative solutions to accelerate access and drive an all-encompassing\, state-of-the-art hub. Prepare for contemporary solutions to optimize your hub model and robust networking opportunities to expand your network and establish powerful partnerships.
URL:https://thebiocalendar.com/event/hub-and-specialty-pharmacy-models-east-4/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/HubE26_600x200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T100000
DTEND;TZID=America/Los_Angeles:20260317T110000
DTSTAMP:20260418T065112
CREATED:20260219T155126Z
LAST-MODIFIED:20260219T155126Z
UID:9928-1773741600-1773745200@thebiocalendar.com
SUMMARY:Demystifying AI in Modern MedTech
DESCRIPTION:In this practical\, example driven webinar\, Battelle Technical Fellow\, Justin Sanchez\, together with leading MedTech experts\, will break down how AI can be applied to accelerate device development while ensuring safety\, reliability\, and regulatory alignment. \nIn this free session\, you will learn:\n– How AI delivers value across medical device development\n– Practical\, real-world examples you can apply\n– A clear\, accessible introduction to AI’s role in modern MedTech
URL:https://thebiocalendar.com/event/demystifying-ai-in-modern-medtech/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-17-26-Battelle-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T110000
DTEND;TZID=America/Los_Angeles:20260317T120000
DTSTAMP:20260418T065112
CREATED:20260219T154840Z
LAST-MODIFIED:20260219T154840Z
UID:9924-1773745200-1773748800@thebiocalendar.com
SUMMARY:Clinical Supply Chain Therapy: Lowering Risk (And Your Blood Pressure)
DESCRIPTION:Join Deputy Chief Editor of Outsourced Pharma Jeff Buguliskis and our experienced panelists as they break down how to transform your CDMO partnerships from sources of stress into strategic assets.  \nWe will share real-world tactics to help you secure your outsourcing strategy\, navigate regional regulatory hurdles\, and prevent costly delays.
URL:https://thebiocalendar.com/event/clinical-supply-chain-therapy-lowering-risk-and-your-blood-pressure/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T160000
DTEND;TZID=America/Los_Angeles:20260317T183000
DTSTAMP:20260418T065112
CREATED:20260217T154830Z
LAST-MODIFIED:20260217T154830Z
UID:9907-1773763200-1773772200@thebiocalendar.com
SUMMARY:BVS' Biotech Community Event at SOVA Science District\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. \nThis is a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nOur last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \n✨ What to Expect: \n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Tacos & Beer: Enjoy delicious Tacos as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-sova-science-district-san-diego-9/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/02/BVS-Biotech-Event-Flyer-03-17-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260318T110000
DTEND;TZID=America/Los_Angeles:20260318T120000
DTSTAMP:20260418T065112
CREATED:20260219T155520Z
LAST-MODIFIED:20260219T155520Z
UID:9932-1773831600-1773835200@thebiocalendar.com
SUMMARY:Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems
DESCRIPTION:Struggling to improve titre\, product quality\, or long-term stability in GS-CHO expression systems? \nIn this free webinar\, learn how optimized vector design — including advanced promoter engineering — can significantly impact biomanufacturing performance. The session highlights the Lonza GSquad® Pro platform and its high-performance LHP-1 promoter\, along with data-driven strategies to improve gene expression control in CHO cells. \nYou’ll gain insights into:\n– Critical CHO vector design elements\n– Performance advantages of next-generation vector platforms\n– Emerging approaches to strengthening expression stability and output
URL:https://thebiocalendar.com/event/enhanced-biotherapeutic-protein-expression-using-advanced-vector-systems/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-18-26-Lonza-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260318T110000
DTEND;TZID=America/Los_Angeles:20260318T120000
DTSTAMP:20260418T065112
CREATED:20260225T145818Z
LAST-MODIFIED:20260225T145818Z
UID:9972-1773831600-1773835200@thebiocalendar.com
SUMMARY:Large Molecule Biologics Delivery: Aligning Formulations\, Doses\, And Devices
DESCRIPTION:Selecting the right route of administration for a complex\, large molecule biologic requires careful alignment of formulation\, dose\, and device strategy. Join Drug Delivery Leader’s next live discussion where experts from Merck\, GSK\, and Drug Hunter Consulting will share key considerations—including formulation complexity\, high-dose delivery\, patient needs\, self-administration\, and transitioning between delivery platforms—using examples from prefilled syringes\, autoinjectors\, and combination products.
URL:https://thebiocalendar.com/event/large-molecule-biologics-delivery-aligning-formulations-doses-and-devices/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-10.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T100000
DTEND;TZID=America/Los_Angeles:20260319T110000
DTSTAMP:20260418T065112
CREATED:20260212T173419Z
LAST-MODIFIED:20260212T173419Z
UID:9899-1773914400-1773918000@thebiocalendar.com
SUMMARY:Ensuring Consistent Quality in Pharmaceutical Water for Injection (WFI) Systems
DESCRIPTION:Water plays a vital role across pharmaceutical manufacturing. It is used as a component of fermentation media\, a solvent in production\, and a cornerstone of cleaning and rinsing procedures.  \nTo safeguard product integrity and protect patients\, disciplined preventive maintenance\, practical risk assessment\, and routine monitoring are essential across the system at every critical point of use. Together\, these measures create a resilient\, well-characterized water system that enables manufacturers to operate with confidence and maintain sustained control over their environments. \nKey Learning Objectives: \n    Understand how water quality can directly impact product safety and compliance\n    Identify practical strategies to reduce contamination\n    Build confidence in maintaining a resilient\, compliant water system
URL:https://thebiocalendar.com/event/ensuring-consistent-quality-in-pharmaceutical-water-for-injection-wfi-systems/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-19-26-Particle-Measuring-Systems-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T110000
DTEND;TZID=America/Los_Angeles:20260319T120000
DTSTAMP:20260418T065112
CREATED:20260210T210536Z
LAST-MODIFIED:20260210T210536Z
UID:9859-1773918000-1773921600@thebiocalendar.com
SUMMARY:Solving Particulates and Material Variability in CGT Manufacturing
DESCRIPTION:Particulates and raw material variability remain two of the toughest\, most talked about hurdles in cell and gene therapy.  \nIn the upcoming Cell & Gene Live\, Anthony Blaszczyk\, Ph.D.\, Senior Scientist at the U.S. Pharmacopeia\, and Basak Clements\, Ph.D.\, Founder and Senior Advisor at biomatria\, join Cell & Gene Chief Editor Erin Harris to examine industry efforts to establish meaningful standards for particulate control (both visible and subvisible) across CGT products. \nThe discussion will address the limitations of current testing methods and the need for a holistic\, risk-based approach that manages particulates from raw materials through final product. We will also explore how variability drives batch failures and CMC delays\, and how emerging digital QC systems and earlier supplier partnerships are helping organizations reduce these risks.
URL:https://thebiocalendar.com/event/solving-particulates-and-material-variability-in-cgt-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_03-CGL-Socials-1000x1250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260319T110000
DTEND;TZID=America/New_York:20260319T133000
DTSTAMP:20260418T065112
CREATED:20260223T181004Z
LAST-MODIFIED:20260223T181004Z
UID:9957-1773918000-1773927000@thebiocalendar.com
SUMMARY:BVS' Waltham/Winter Street Biotech Community Expo\, Waltham
DESCRIPTION:We are very excited to invite you to our indoor BVS Waltham/Winter Street Biotech Community Expo! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nWe are inviting all research scientists from the institutes\, biotech/pharma and other companies along Winter Street and surrounding areas to attend this event. \n✨ What to Expect:\n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Food & Drinks: Enjoy delicious food & refreshments as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-waltham-winter-street-biotech-community-expo-waltham-4/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/02/BVS-Biotech-Event-Flyer-03-19-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T130000
DTEND;TZID=America/Los_Angeles:20260319T140000
DTSTAMP:20260418T065112
CREATED:20260219T155819Z
LAST-MODIFIED:20260219T155819Z
UID:9936-1773925200-1773928800@thebiocalendar.com
SUMMARY:Accelerating Vector Construction-to-IND: Achieving a 9-Month Timeline Through Integrated Cell Line Development
DESCRIPTION:Join this free webinar to see how Samsung Biologics integrates in-house vector construction and Master Cell Bank (MCB) manufacturing to streamline the VC-to-IND journey to approximately 9 months. \nYou’ll learn how tighter alignment between vector design and cell banking:\n– Reduces handoffs and accelerates decision-making\n– Improves data continuity and risk management\n– Enhances predictability in early-stage development
URL:https://thebiocalendar.com/event/accelerating-vector-construction-to-ind-achieving-a-9-month-timeline-through-integrated-cell-line-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-19-26-Samsung-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260418T065112
CREATED:20260218T112126Z
LAST-MODIFIED:20260218T112126Z
UID:9911-1774224000-1774569599@thebiocalendar.com
SUMMARY:DCAT Week
DESCRIPTION:DCAT Week is the premier global event convening annually in New York City for companies engaged in the Bio/Pharmaceutical business ecosystem. It is hosted by the Drug\, Chemical & Associated Technologies Association (DCAT)\, a not-for-profit\, corporate member-supported\, global business development association whose unique membership model integrates both innovator and generic drug manufacturers with suppliers of ingredients\, development and manufacturing services\, and related technologies.
URL:https://thebiocalendar.com/event/dcat-week/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260326
DTSTAMP:20260418T065112
CREATED:20251105T134054Z
LAST-MODIFIED:20251105T134115Z
UID:9439-1774224000-1774483199@thebiocalendar.com
SUMMARY:BIO-Europe Spring
DESCRIPTION:BIO-Europe Spring is a leading springtime partnering conference for the biopharma and life sciences industries that connects companies\, academics\, and investors to foster strategic partnerships. It offers a hybrid experience with both in-person and online components\, featuring one-on-one meetings facilitated by the partneringONE® platform\, along with workshops\, company presentations\, and an exhibition. The event aims to cultivate new collaborations and partnerships by bringing together executives from around the world to network and discuss the latest industry challenges and innovations.
URL:https://thebiocalendar.com/event/bio-europe-spring-2/
LOCATION:Lisbon\, Lisbon\, Portugal
CATEGORIES:Expo,Featured,Forum,Partnering
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/bes.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260323T080000
DTEND;TZID=America/Los_Angeles:20260323T153000
DTSTAMP:20260418T065112
CREATED:20260112T174740Z
LAST-MODIFIED:20260112T174911Z
UID:9776-1774252800-1774279800@thebiocalendar.com
SUMMARY:New Jersey Inaugural Symposium for Life Science Innovation and Development
DESCRIPTION:THEME | Beyond the Medicine Chest of the World: Looking Towards the Future of Health and Medicine \nA Special Full-Day Conference for Senior Executives and Key Thought Leaders in the Life Sciences Industry \nMonday\, March 23\n8:00am — 2:30pm\nReception to Follow \nThe Rutgers Club\n85 Avenue E\, 2nd Fl.\nPiscataway\, NJ 08854
URL:https://thebiocalendar.com/event/new-jersey-inaugural-symposium-for-life-science-innovation-and-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Jersey-Banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260323T100000
DTEND;TZID=America/New_York:20260325T163000
DTSTAMP:20260418T065112
CREATED:20260107T102424Z
LAST-MODIFIED:20260107T102738Z
UID:9720-1774260000-1774456200@thebiocalendar.com
SUMMARY:Life Sciences Accounting & Reporting Congress 2026
DESCRIPTION:The premier event for life sciences CFOs\, controllers and accounting leaders returns for its 21st year as the essential forum for navigating today’s most pressing financial challenges. As regulations evolve at unprecedented speed and new technologies transform financial operations\, this is where 350+ industry leaders converge to share proven strategies\, explore emerging solutions\, and build the connections needed to stay ahead. Through specialized sessions for companies of all sizes – from emerging biotechs to global enterprises – you’ll gain actionable insights to tackle regulatory shifts\, optimize accounting practices\, and evaluate financial technologies that are reshaping the sector – all while building valuable relationships with peers who understand your unique challenges. (CPE accredited)
URL:https://thebiocalendar.com/event/life-sciences-accounting-reporting-congress-2026/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/LS_Accounting_Reporting-MediaPartner_Big4Bio-Listing-1.png
END:VEVENT
END:VCALENDAR